Wenbo B. Niu

No. 12, Jiankang Road
Shijiazhuang, 050000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Artemisinin inhibits colorectal cancer progression via the FAM83A-AS1/HIF-1α axis.

Artemisinin inhibits colorectal cancer progression via the FAM83A-AS1/HIF-1α axis.

Journal: Journal of gastrointestinal oncology

Published: May 08, 2026

Dissecting immunosuppressive microenvironment in chemotherapy-resistant colorectal cancer through single-cell transcriptomic analysis.

Dissecting immunosuppressive microenvironment in chemotherapy-resistant colorectal cancer through single-cell transcriptomic analysis.

Journal: Translational oncology

Published: April 20, 2026

An exploratory multimodal pipeline for recurrence prediction in CRC with XELOX therapy.

An exploratory multimodal pipeline for recurrence prediction in CRC with XELOX therapy.

Journal: Scientific reports

Published: February 28, 2026

Methodological Reflections on the Development of Breath Volatile Organic Compounds Models in Colorectal Cancer Screening.

Methodological Reflections on the Development of Breath Volatile Organic Compounds Models in Colorectal Cancer Screening.

Journal: Diseases of the colon and rectum

Published: December 19, 2025

Short-Course Radiotherapy-Based Total Neoadjuvant Therapy plus Tislelizumab for Locally Advanced Rectal Cancer (Neo-STAR): Early Outcomes of a Randomized Phase II Trial.

Short-Course Radiotherapy-Based Total Neoadjuvant Therapy plus Tislelizumab for Locally Advanced Rectal Cancer (Neo-STAR): Early Outcomes of a Randomized Phase II Trial.

Journal: Cancer communications (London, England)

Published: December 17, 2025

[18F]FDG PET/CT versus pelvic MRI in preoperative diagnosis of lateral lymph node metastasis in rectal cancer: a meta-analysis.

[18F]FDG PET/CT versus pelvic MRI in preoperative diagnosis of lateral lymph node metastasis in rectal cancer: a meta-analysis.

Journal: Clinical radiology

Published: November 05, 2025

Distinct trajectories of low anterior resection syndrome following ileostomy reversal.

Distinct trajectories of low anterior resection syndrome following ileostomy reversal.

Journal: Frontiers in medicine

Published: October 30, 2025

Association between pre-reversal systemic inflammation response index and low anterior resection syndrome in rectal cancer patients: a retrospective cohort study.

Association between pre-reversal systemic inflammation response index and low anterior resection syndrome in rectal cancer patients: a retrospective cohort study.

Journal: Frontiers in oncology

Published: September 24, 2025

The Missing Link: Fusobacterium nucleatum in Post-Ileectomy Colorectal Carcinogenesis.

The Missing Link: Fusobacterium nucleatum in Post-Ileectomy Colorectal Carcinogenesis.

Journal: Inflammatory bowel diseases

Published: September 16, 2025

Rare MSI-H hepatoid adenocarcinoma of the colon with BRAF V600E mutation achieving long-term disease-free survival after adjuvant envafolimab: a case report.

Rare MSI-H hepatoid adenocarcinoma of the colon with BRAF V600E mutation achieving long-term disease-free survival after adjuvant envafolimab: a case report.

Journal: Frontiers in immunology

Published: September 03, 2025

ALDH1A1 promotes colorectal cancer metastasis through activating the notch signaling pathway.

ALDH1A1 promotes colorectal cancer metastasis through activating the notch signaling pathway.

Journal: Medical oncology (Northwood, London, England)

Published: May 15, 2025

Immune activation following PD-L1 inhibitor plus chemoradiotherapy in locally advanced rectal cancer: a retrospective, single-arm study.

Immune activation following PD-L1 inhibitor plus chemoradiotherapy in locally advanced rectal cancer: a retrospective, single-arm study.

Journal: Frontiers in immunology

Published: April 27, 2025

Showing 1-12 of 35

Last Updated: 09/26/2026